MUMBAI, India, Sept. 28 -- Intellectual Property India has published a patent application (202518018028 A) filed by Regeneron Pharmaceuticals, Inc. on February 28, 2025, for Novel Cho Integration Sites And Uses Thereof.
Inventors include Shen, Ying; Burakov, Darya; Chen, Gang; and Fandl, James P..
The application for the patent was published on September 25, 2026, under issue no. 39/2026.
Abstract: Expression-enhancing nucleotide sequences for eukaryotic expressions systems are provided that allow for enhanced and stable expression of recombinant proteins in eukaryotic cells. Genomic integration sites providing enhanced expression and methods of use thereof are provided for expression of a gene of interest in a eukaryotic cell. Chromosomal loci, sequences, and vectors are provided for enhanced and stable expression of genes in eukaryotic cells.
Disclaimer: Curated by HT Syndication.
